Managed Care Pharmacy and Medical Drug Policies Archive (2024)

"Policy or procedure" shall mean a requirement governing the administration of managed care organizations specific to billing guidelines, medical management and utilization review guidelines, case management guidelines, claims processing guidelines and edits, grievance and appeals procedures and process, other guidelines or manuals containing pertinent information related to operations and pre-processing claims, and core benefits and services.

Below are items previously posted for public comment:

Item Number Policy/Procedure Date Posted Comment Period Closed Status Document Links
2024-HB-MED-486 Botulinum Toxin 12/13/24 1/27/25 Complete Botulinum Toxin
2024-LHCC-MED-675 Axatilimab-csfr (Niktimvo) 12/13/24 1/27/25 Complete Axatilimab-csfr (Niktimvo)
2024-LHCC-MED-676 Denileukin Diftitox-cxdl (Lymphir) 12/13/24 1/27/25 Complete Denileukin Diftitox-cxdl (Lymphir)
2024-LHCC-MED-677 Palopegteriparatide (Yorvipath) 12/13/24 1/27/25 Complete Palopegteriparatide (Yorvipath)
2024-LHCC-MED-665 Mirvetuximab soravatansine-gynx (Elahere) 12/13/24 1/27/25 Complete Mirvetuximab soravatansine-gynx (Elahere)
2024-LHCC-MED-666 Dornase Alfa (Pulmozyme) 12/13/24 1/27/25 Complete Dornase Alfa (Pulmozyme)
2024-LHCC-MED-667 Ofatumumab (Arzerra) 12/13/24 1/27/25 Complete Ofatumumab (Arzerra)
2024-LHCC-MED-668 Metreleptin (Myalept) 12/13/24 1/27/25 Complete Metreleptin (Myalept)
2024-LHCC-MED-669 Bremelanotide (Vyleesi) 12/13/24 1/27/25 Complete Bremelanotide (Vyleesi)
2024-LHCC-MED-670 Belantamab Mafodotin-blmf (Blenrep) 12/13/24 1/27/25 Complete Belantamab Mafodotin-blmf (Blenrep)
2024-LHCC-MED-671 Mitomycin for Pyelocalyceal Solution (Jelmyto) 12/13/24 1/27/25 Complete Mitomycin for Pyelocalyceal Solution (Jelmyto)
2024-LHCC-MED-672 Tebentafusp-tebn (Kimmtrak) 12/13/24 1/27/25 Complete Tebentafusp-tebn (Kimmtrak)
2024-LHCC-MED-673 Fecal Microbiota, Live-jslm (Rebyota) 12/13/24 1/27/25 Complete Fecal Microbiota, Live-jslm (Rebyota)
2024-LHCC-MED-674 Glycopyrronium (Qbrexza) 12/13/24 1/27/25 Complete Glycopyrronium (Qbrexza)
2024-LHCC-MED-661 Teclistamab-cqyv (Tecvayli) 12/13/24 1/27/25 Complete Teclistamab-cqyv (Tecvayli)
2024-LHCC-MED-662 Melphalan Flufenamide (Pepaxto) 12/13/24 1/27/25 Complete Melphalan Flufenamide (Pepaxto)
2024-LHCC-MED-663 Levoleucovorin (Fusilev, Khapzory) 12/13/24 1/27/25 Complete Levoleucovorin (Fusilev, Khapzory)
2024-LHCC-MED-664 Hyaluronate Derivatives 12/13/24 1/27/25 Complete Hyaluronate Derivatives
2024-LHCC-MED-653 Lutetium Lu 177 vipivotide tetraxetan (Pluvicto) 12/13/24 1/27/25 Complete Lutetium Lu 177 vipivotide tetraxetan (Pluvicto)
2024-LHCC-MED-654 Isatuximab-irfc (Sarclisa) 12/13/24 1/27/25 Complete Isatuximab-irfc (Sarclisa)
2024-LHCC-MED-655 Baclofen (Fleqsuvy, Gablofen, Lioresal, Lyvispah, Ozobax) 12/13/24 1/27/25 Complete Baclofen (Fleqsuvy, Gablofen, Lioresal, Lyvispah, Ozobax)
2024-LHCC-MED-656 Valrubicin (Valstar) 12/13/24 1/27/25 Complete Valrubicin (Valstar)
2024-LHCC-MED-657 Tafasitamab-cxix (Monjuvi) 12/13/24 1/27/25 Complete Tafasitamab-cxix (Monjuvi)
2024-LHCC-MED-658 Mogamulizumab-kpkc (Poteligeo) 12/13/24 1/27/25 Complete Mogamulizumab-kpkc (Poteligeo)
2024-LHCC-MED-659 Desmopressin Acetate (DDAVP) 12/13/24 1/27/25 Complete Desmopressin Acetate (DDAVP)
2024-LHCC-MED-660 Irinotecan Liposome (Onivyde) 12/13/24 1/27/25 Complete Irinotecan Liposome (Onivyde)
2024-UHC-MED-226  Maximum Dosage 12/13/24 1/27/25 Complete Maximum Dosage
2024-UHC-MED-227 Xiaflex 12/13/24 1/27/25 Complete Xiaflex
2024-ACLA-MED-91 Complement inhibitors 12/13/24 1/27/25 Complete Complement inhibitors
2024-ACLA-MED-92 Veopoz 12/13/24 1/27/25 Complete Veopoz
2024-ACLA-MED-93 Rytelo 12/13/24 1/27/25 Complete Rytelo
2024-ACLA-MED-94 Chronic Inflammatory Demyelinating Polyneuropathy 12/13/24 1/27/25 Complete Chronic Inflammatory Demyelinating Polyneuropathy
2024-ACLA-MED-95 Tecelra 12/13/24 1/27/25 Complete Tecelra
2024-LHCC-MED-646 Pembrolizumab (Keytruda) 12/5/24 1/19/25 Complete Pembrolizumab (Keytruda)
2024-LHCC-MED-647 Fam-trastuzumab deruxtecan-nxki (Enhertu) 12/5/24 1/19/25 Complete Fam-trastuzumab deruxtecan-nxki (Enhertu)
2024-LHCC-MED-648 Lutetium Lu 177 Dotatate (Lutathera) 12/5/24 1/19/25 Complete Lutetium Lu 177 Dotatate (Lutathera)
2024-LHCC-MED-649 Daratumumab Daratumumab-Hyaluronidase-fihj (Darzalex, Darzalex, Faspro) 12/5/24 1/19/25 Complete Daratumumab Daratumumab-Hyaluronidase-fihj (Darzalex, Darzalex, Faspro)
2024-LHCC-MED-650 Ciltacabtagene Autoleucel (Carvykti) 12/5/24 1/19/25 Complete Ciltacabtagene Autoleucel (Carvykti)
2024-LHCC-MED-651 Cerliponase alfa (Brineura) 12/5/24 1/19/25 Complete Cerliponase alfa (Brineura)
2024-LHCC-MED-652 Fibrinogen concentrate (human) (Fibryga, RiaSTAP) 12/5/24 1/19/25 Complete Fibrinogen concentrate (human) (Fibryga, RiaSTAP)
2024-LHCC-MED-634 Ranibizumab (Lucentis, Susvimo), Lucentis Biosimilars 12/5/24 1/19/25 Complete Ranibizumab (Lucentis, Susvimo), Lucentis Biosimilars
2024-LHCC-MED-635 Nivolumab and Relatlimab (Opdualag) 12/5/24 1/19/25 Complete Nivolumab and Relatlimab (Opdualag)
2024-LHCC-MED-636 Amivantamab-vmjw (Rybrevant)  12/5/24 1/19/25 Complete Amivantamab-vmjw (Rybrevant) 
2024-LHCC-MED-637 Brentuximab Vedotin (Adcetris) 12/5/24 1/19/25 Complete Brentuximab Vedotin (Adcetris)
2024-LHCC-MED-638 Furosemide (Furoscix) 12/5/24 1/19/25 Complete Furosemide (Furoscix)
2024-LHCC-MED-639 Vutrisiran (Amvuttra) 12/5/24 1/19/25 Complete Vutrisiran (Amvuttra)
2024-LHCC-MED-640 Aflibercept (Eylea) 12/5/24 1/19/25 Complete Aflibercept (Eylea)
2024-LHCC-MED-641 Denosumab (Xgeva) 12/5/24 1/19/25 Complete Denosumab (Xgeva)
2024-LHCC-MED-642 Paclitaxel protein-bound (Abraxane) 12/5/24 1/19/25 Complete Paclitaxel protein-bound (Abraxane)
2024-LHCC-MED-643 Tremelimumab-actl (Imjudo) 12/5/24 1/19/25 Complete Tremelimumab-actl (Imjudo)
2024-LHCC-MED-644 Nadofaragene Firadenovec-vncg (Adstiladrin) 12/5/24 1/19/25 Complete Nadofaragene Firadenovec-vncg (Adstiladrin)
2024-LHCC-MED-645 Ophthalmic Riboflavin (Photrexa, Photrexa Viscous) 12/5/24 1/19/25 Complete Ophthalmic Riboflavin (Photrexa, Photrexa Viscous)
2024-UHC-MED-223 Complement inhibitors 12/5/24 1/19/25 Complete Complement inhibitors
2024-UHC-MED-224 Review at launch new to market medications 12/5/24 1/19/25 Complete Review at launch new to market medications
2024-HB-MED-475 Tegsedi (inotersen) 11/27/24 1/11/25 Complete Tegsedi (inotersen)
2024-HB-MED-476 Denosumab 11/27/24 1/11/25 Complete Denosumab
2024-HB-MED-478 Vyvgart (efgartigimod alfa-fcab) and Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-gvfc) 11/27/24 1/11/25 Complete Vyvgart (efgartigimod alfa-fcab) and Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-gvfc)
2024-HB-MED-480 Darzalex (daratumumab) and Darzalex Faspro (daratumumab and hyaluronidase-fihj) 11/27/24 1/11/25 Complete Darzalex (daratumumab) and Darzalex Faspro (daratumumab and hyaluronidase-fihj)
2024-HB-MED-481 Epkinly (epcoritamab-bysp) 11/27/24 1/11/25 Complete Epkinly (epcoritamab-bysp)
2024-HB-MED-482 Infertility and HCG Agents 11/27/24 1/11/25 Complete Infertility and HCG Agents
2024-HB-MED-484 Sandostatin and Sandostatin LAR (Octreotide) / Octreotide Agents 11/27/24 1/11/25 Complete Sandostatin and Sandostatin LAR (Octreotide) / Octreotide Agents
2024-HB-MED-485 Xenpozyme (olipudase alfa-rpcp) 11/27/24 1/11/25 Complete Xenpozyme (olipudase alfa-rpcp)
2024-HB-MED-465 Rytelo (imetelstat) 11/26/24 1/10/25 Complete Rytelo (imetelstat)
2024-HB-MED-466 Levoleucovorin Agents 11/26/24 1/10/25 Complete Levoleucovorin Agents
2024-HB-MED-467 Istodax (romidepsin) 11/26/24 1/10/25 Complete Istodax (romidepsin)
2024-HB-MED-468  Iron agents 11/26/24 1/10/25 Complete Iron agents
2024-HB-MED-469 Monjuvi (tafasitamab-cxix) 11/26/24 1/10/25 Complete Monjuvi (tafasitamab-cxix)
2024-HB-MED-470  Opdualag (nivolumab and relatlimab-rmbw) 11/26/24 1/10/25 Complete Opdualag (nivolumab and relatlimab-rmbw)
2024-HB-MED-471 Jemperli (dostarlimab-gxly) 11/26/24 1/10/25 Complete Jemperli (dostarlimab-gxly)
2024-HB-MED-472 Beyfortus (nirsevimab) 11/26/24 1/10/25 Complete Beyfortus (nirsevimab)
2024-HB-MED-473 Onpattro (patisiran) 11/26/24 1/10/25 Complete Onpattro (patisiran)
2024-HB-MED-474 Amvuttra (vulrisiran) 11/26/24 1/10/25 Complete Amvuttra (vulrisiran)
2024-PHARM-113 POS Dermatology - Atopic Dermatitis, Immunomodulators 11/20/24 1/4/25 Complete POS Dermatology - Atopic Dermatitis, Immunomodulators
2024-PHARM-111 Depression-Antidepressants, Other 11/14/24 12/29/24 Complete Depression-Antidepressants, Other
2024-PHARM-112 PDL January 1, 2025 11/14/24 12/29/24 Complete PDL January 1, 2025
2024-PHARM-110 Spinal Muscular Atrophy 11/8/24 12/23/24 Complete Spinal Muscular Atrophy
2024-PHARM-87 Alyglo 11/6/24 12/21/24 Complete Alyglo
2024-PHARM-88 Diabetes, Hypoglycemics - Insulins and Related Agents 11/6/24 12/21/24 Complete Diabetes, Hypoglycemics - Insulins and Related Agents
2024-PHARM-89 Diabetes, Hypoglycemics - Meglitinides 11/6/24 12/21/24 Complete Diabetes, Hypoglycemics - Meglitinides
2024-PHARM-90 Diabetes, Hypoglycemics - SGLT2 11/6/24 12/21/24 Complete Diabetes, Hypoglycemics - SGLT2
2024-PHARM-91 Diabetes, Hypoglycemics - Sulfonylureas 11/6/24 12/21/24 Complete Diabetes, Hypoglycemics - Sulfonylureas
2024-PHARM-92 Digestive Disorders Bile Acid Salts 11/6/24 12/21/24 Complete Digestive Disorders Bile Acid Salts
2024-PHARM-93 Elevidys 11/6/24 12/21/24 Complete Elevidys
2024-PHARM-94 GI Motility Chronic 11/6/24 12/21/24 Complete GI Motility Chronic
2024-PHARM-95 H Pylori Treatment 11/6/24 12/21/24 Complete H Pylori Treatment
2024-PHARM-96 Kisunla 11/6/24 12/21/24 Complete Kisunla
2024-PHARM-97 Kisunla Form 11/6/24 12/21/24 Complete Kisunla Form
2024-PHARM-98 Pain Management - Cytokine and CAM Antagonists 11/6/24 12/21/24 Complete Pain Management - Cytokine and CAM Antagonists
2024-PHARM-99 POS ADD/ADHD - Stimulants and Related Agents 11/6/24 12/21/24 Complete POS ADD/ADHD - Stimulants and Related Agents
2024-PHARM-100 POS Daxxify 11/6/24 12/21/24 Complete POS Daxxify
2024-PHARM-101 POS Korlym 11/6/24 12/21/24 Complete POS Korlym
2024-PHARM-102 POS Pain Management - Cytokine and CAM Antagonists 11/6/24 12/21/24 Complete POS Pain Management - Cytokine and CAM Antagonists
2024-PHARM-103 POS PiaSky 11/6/24 12/21/24 Complete POS PiaSky
2024-PHARM-104 POS Rextovy 11/6/24 12/21/24 Complete POS Rextovy
2024-PHARM-105 Quantity Limit Override - Humira 80mg 11/6/24 12/21/24 Complete Quantity Limit Override - Humira 80mg
2024-PHARM-106 Rezdiffra 11/6/24 12/21/24 Complete Rezdiffra
2024-PHARM-107 Skyclarys 11/6/24 12/21/24 Complete Skyclarys
2024-PHARM-108 Stimulants and Related Agents 11/6/24 12/21/24 Complete Stimulants and Related Agents
2024-PHARM-109 Xolremdi 11/6/24 12/21/24 Complete Xolremdi
2024-LHCC-MED-616 Ketamine (Ketalar) 11/1/24 12/16/24 Complete Ketamine (Ketalar)
2024-LHCC-MED-617 Eculizumab (Soliris, Bkemv, Epysqli) 11/1/24 12/16/24 Complete Eculizumab (Soliris, Bkemv, Epysqli)
2024-LHCC-MED-618 Burosumab-twza (Crysvita) 11/1/24 12/16/24 Complete Burosumab-twza (Crysvita)
2024-LHCC-MED-619 Iptacopan (Fabhalta) 11/1/24 12/16/24 Complete Iptacopan (Fabhalta)
2024-LHCC-MED-620 Inotuzumab Ozogamicin (Besponsa) 11/1/24 12/16/24 Complete Inotuzumab Ozogamicin (Besponsa)
2024-LHCC-MED-621 Durvalumab (Imfinzi) 11/1/24 12/16/24 Complete Durvalumab (Imfinzi)
2024-LHCC-MED-622 Tisotumab Vedotin-tftv (Tivdak) 11/1/24 12/16/24 Complete Tisotumab Vedotin-tftv (Tivdak)
2024-LHCC-MED-623 Toripalimab (Loqtorzi) 11/1/24 12/16/24 Complete Toripalimab (Loqtorzi)
2024-LHCC-MED-624 Avacincaptad pegol (Izervay) 11/1/24 12/16/24 Complete Avacincaptad pegol (Izervay)
2024-LHCC-MED-625 Deferoxamine (Desferal) 11/1/24 12/16/24 Complete Deferoxamine (Desferal)
2024-LHCC-MED-626 Ferumoxytol (Feraheme) 11/1/24 12/16/24 Complete Ferumoxytol (Feraheme)
2024-LHCC-MED-627 Ferric Carboxymaltose (Injectafer) 11/1/24 12/16/24 Complete Ferric Carboxymaltose (Injectafer)
2024-LHCC-MED-628 Lurbinectedin (Zepzelca) 11/1/24 12/16/24 Complete Lurbinectedin (Zepzelca)
2024-LHCC-MED-629 Loncastuximab Tesirine-lpyl (Zynlonta) 11/1/24 12/16/24 Complete Loncastuximab Tesirine-lpyl (Zynlonta)
2024-LHCC-MED-630 Dostarlimab-gxly (Jemperli) 11/1/24 12/16/24 Complete Dostarlimab-gxly (Jemperli)
2024-LHCC-MED-631 Polatuzumab Vedotin-piiq (Polivy) 11/1/24 12/16/24 Complete Polatuzumab Vedotin-piiq (Polivy)
2024-UHC-MED-225 Brineura 10/31/24 12/15/24 Complete Brineura
2024-MED-UHC-222 Oncology Medications Clinical Coverage 10/23/24 12/7/24 Complete Oncology Medications Clinical Coverage
2024-MED-HB-458 Breynazi 10/23/24 12/7/24 Complete Breynazi
2024-MED-HB-459 Imdelitra 10/23/24 12/7/24 Complete Imdelitra
2024-MED-HB-460 Anktiva 10/23/24 12/7/24 Complete Anktiva
2024-MED-HB-461 Pemetrexed (Alimta, Pemfexy, Pemrydi) 10/23/24 12/7/24 Complete Pemetrexed (Alimta, Pemfexy, Pemrydi)
2024-MED-HB-462 Radioimmunotherapy 10/23/24 12/7/24 Complete Radioimmunotherapy
2024-MED-HB-463 Trastuzumab Agents 10/23/24 12/7/24 Complete Trastuzumab Agents
2024-MED-HB-464 Complement C5 Inhibitors 10/23/24 12/7/24 Complete Complement C5 Inhibitors
2024-HB-MED-446  Keytruda 10/17/24 12/1/24 Complete Keytruda
2024-HB-MED-447 Elrexfio, Ngenia, Pombiliti other requirements 10/17/24 12/1/24 Complete Elrexfio, Ngenia, Pombiliti other requirements
2024-HB-MED-448 Tecentriq 10/17/24 12/1/24 Complete Tecentriq
2024-HB-MED-449 Imfinzi 10/17/24 12/1/24 Complete Imfinzi
2024-HB-MED-450 Polivy 10/17/24 12/1/24 Complete Polivy
2024-HB-MED-451 Libtayo 10/17/24 12/1/24 Complete Libtayo
2024-HB-MED-452  Enhertu  10/17/24 12/1/24 Complete Enhertu 
2024-HB-MED-453 Tepezza 10/17/24 12/1/24 Complete Tepezza
2024-HB-MED-454 Trodelvy 10/17/24 12/1/24 Complete Trodelvy
2024-HB-MED-455 Imcivree 10/17/24 12/1/24 Complete Imcivree
2024-HB-MED-456 Rybrevant 10/17/24 12/1/24 Complete Rybrevant
2024-HB-MED-457 Elahere 10/17/24 12/1/24 Complete Elahere
2024-HB-MED-433 Winrevair 9/26/24 11/10/24 Complete Winrevair
2024-HB-MED-434 Gazyva 9/26/24 11/10/24 Complete Gazyva
2024-HB-MED-435 Opdivo 9/26/24 11/10/24 Complete Opdivo
2024-HB-MED-436 Scenesse 9/26/24 11/10/24 Complete Scenesse
2024-HB-MED-437 Revcovi 9/26/24 11/10/24 Complete Revcovi
2024-HB-MED-438 Ycanth 9/26/24 11/10/24 Complete Ycanth
2024-HB-MED-439 Tevimbra 9/26/24 11/10/24 Complete Tevimbra
2024-HB-MED-440 Adcetris 9/26/24 11/10/24 Complete Adcetris
2024-HB-MED-441 Doxorubicin 9/26/24 11/10/24 Complete Doxorubicin
2024-HB-MED-442 Torisel 9/26/24 11/10/24 Complete Torisel
2024-HB-MED-443 Vectibix 9/26/24 11/10/24 Complete Vectibix
2024-HB-MED-444 Erbitux 9/26/24 11/10/24 Complete Erbitux
2024-HB-MED-445 Cyramza 9/26/24 11/10/24 Complete Cyramza
2024-HB-MED-402 iDose TR 9/26/24 11/10/24 Complete iDose TR
2024-HB-MED-403 Amtagvi 9/26/24 11/10/24 Complete Amtagvi
2024-HB-MED-405 Elzonris 9/26/24 11/10/24 Complete Elzonris
2024-HB-MED-406 Mozobil 9/26/24 11/10/24 Complete Mozobil
2024-HB-MED-407 Ixempra 9/26/24 11/10/24 Complete Ixempra
2024-HB-MED-408 Docetaxel (Taxotere) 9/26/24 11/10/24 Complete Docetaxel (Taxotere)
2024-HB-MED-409 Asparagine Specific Enzymes 9/26/24 11/10/24 Complete Asparagine Specific Enzymes
2024-HB-MED-410 Vidaza 9/26/24 11/10/24 Complete Vidaza
2024-HB-MED-411 Abraxane 9/26/24 11/10/24 Complete Abraxane
2024-HB-MED-412 Halaven 9/26/24 11/10/24 Complete Halaven
2024-HB-MED-413 Zaltrap 9/26/24 11/10/24 Complete Zaltrap
2024-HB-MED-414 Perjeta 9/26/24 11/10/24 Complete Perjeta
2024-HB-MED-415 Xofigo 9/26/24 11/10/24 Complete Xofigo
2024-HB-MED-416 Sylvant 9/26/24 11/10/24 Complete Sylvant
2024-HB-MED-417 Kadcyla 9/26/24 11/10/24 Complete Kadcyla
2024-HB-MED-418 Bendamustine 9/26/24 11/10/24 Complete Bendamustine
2024-HB-MED-419 Empliciti 9/26/24 11/10/24 Complete Empliciti
2024-HB-MED-420 Yervoy 9/26/24 11/10/24 Complete Yervoy
2024-HB-MED-421 Kyprolis 9/26/24 11/10/24 Complete Kyprolis
2024-HB-MED-422 Arzerra 9/26/24 11/10/24 Complete Arzerra
2024-HB-MED-423 Blincyto 9/26/24 11/10/24 Complete Blincyto
2024-HB-MED-424 Bavencio 9/26/24 11/10/24 Complete Bavencio
2024-HB-MED-425 Besponsa 9/26/24 11/10/24 Complete Besponsa
2024-HB-MED-426 Mylotarg 9/26/24 11/10/24 Complete Mylotarg
2024-HB-MED-427 Melanoma Vaccines 9/26/24 11/10/24 Complete Melanoma Vaccines
2024-HB-MED-428 Padcev 9/26/24 11/10/24 Complete Padcev
2024-HB-MED-429  Sarclisa 9/26/24 11/10/24 Complete Sarclisa
2024-HB-MED-430 Adstiladrin 9/26/24 11/10/24 Complete Adstiladrin
2024-HB-MED-431 Lunsumio 9/26/24 11/10/24 Complete Lunsumio
2024-HB-MED-432 Nexobrid 9/26/24 11/10/24 Complete Nexobrid
2024-LHCC-MED-604 Ferric Derisomaltose (Monoferric) 9/17/24 11/1/24 Complete Ferric Derisomaltose (Monoferric)
2024-LHCC-MED-605  Idecabtagene vicleucel (Abecma) 9/17/24 11/1/24 Complete Idecabtagene vicleucel (Abecma)
2024-LHCC-MED-606 Lisocabtagene maraleucel (Breyanzi) 9/17/24 11/1/24 Complete Lisocabtagene maraleucel (Breyanzi)
2024-LHCC-MED-607 Ciltacabtagene Autoleucel (Carvykti) 9/17/24 11/1/24 Complete Ciltacabtagene Autoleucel (Carvykti)
2024-LHCC-MED-608 Mitoxantrone 9/17/24 11/1/24 Complete Mitoxantrone
2024-LHCC-MED-609 Daptomycin (Cubicin, Cubicin RF, Dapzura RT) 9/17/24 11/1/24 Complete Daptomycin (Cubicin, Cubicin RF, Dapzura RT)
2024-LHCC-MED-610 Lanreotide (Somatuline Depot and Unbranded) 9/17/24 11/1/24 Complete Lanreotide (Somatuline Depot and Unbranded)
2024-LHCC-MED-611 Aflibercept (Eylea, Eylea HD) 9/17/24 11/1/24 Complete Aflibercept (Eylea, Eylea HD)
2024-LHCC-MED-612 Sodium Phenylbutyrate-Taurursodiol (Relyvrio) 9/17/24 11/1/24 Complete Sodium Phenylbutyrate-Taurursodiol (Relyvrio)
2024-LHCC-MED-602 Glofitamab-gxbm (Columvi) 9/17/24 11/1/24 Complete Glofitamab-gxbm (Columvi)
2024-LHCC-MED-603 Epcoritamab-bysp (Epkinly) 9/17/24 11/1/24 Complete Epcoritamab-bysp (Epkinly)
2024-LHCC-MED-598 Tarlatamab-dlle (imdelltra) 9/17/24 11/1/24 Complete Tarlatamab-dlle (imdelltra)
2024-LHCC-MED-599 Tislelizumab-jsgr (Tevimbra) 9/17/24 11/1/24 Complete Tislelizumab-jsgr (Tevimbra)
2024-LHCC-MED-600 Imetelstat (Rytelo) 9/17/24 11/1/24 Complete Imetelstat (Rytelo)
2024-PHARM-86 Diabetes - Hypoglycemics, Incretin
Mimetics/Enhancers
9/17/24 N/A Approved Diabetes - Hypoglycemics, Incretin
Mimetics/Enhancers Met Imminent Peril Justification
2024-PHARM-84 GLP-1/DPP-4 Therapeutic Duplication 9/4/24 N/A Approved GLP-1/DPP-4 Therapeutic Duplication Met Imminent Peril Justification
2024-PHARM-85 GLP-1 Maximum Dose/Quantity Limit  9/4/24 N/A Approved GLP-1 Maximum Dose/Quantity Limit  Met Imminent Peril Justification
2024-LHCC-MED-509 No Coverage Criteria 9/4/24 10/19/24 Pending No Coverage Criteria
2024-LHCC-MED-508 Off-label Use 9/4/24 10/19/24 Pending Off-label Use
2024-UHC-MED-220 Neonatal receptor blockers 9/4/24 10/19/24 Pending Neonatal receptor blockers
2024-UHC-MED-221 Provider administered drugs site of care 9/4/24 10/19/24 Pending Provider administered drugs site of care
2024-ACLA-MED-75 Amtagvi 9/4/24 10/19/24 Pending Amtagvi
2024-ACLA-MED-85 Anti-CD19 CAR-T Immunotherapies 9/4/24 10/19/24 Pending Anti-CD19 CAR-T Immunotherapies
2024-ACLA-MED-86 BCMA Directed CART-T Therapy 9/4/24 10/19/24 Pending BCMA Directed CART-T Therapy
2024-ACLA-MED-87 Brineura 9/4/24 10/19/24 Pending Brineura
2024-ACLA-MED-88  Complement Inhibitors 9/4/24 10/19/24 Pending Complement Inhibitors
2024-ACLA-MED-89 Omisirge 9/4/24 10/19/24 Pending Omisirge
2024-ACLA-MED-90 Rituximab 9/4/24 10/19/24 Pending Rituximab
2024-PHARM-61 Asthma Immunomodulators 8/5/24 9/19/24 Complete Asthma Immunomodulators
2024-PHARM-62 Beqvez 8/5/24 9/19/24 Complete Beqvez
2024-PHARM-63 Colony Stimulating Factors 8/5/24 9/19/24 Complete Colony Stimulating Factors
2024-PHARM-64 Digestive Disorders - Bile Acid Salts 8/5/24 9/19/24 Complete Digestive Disorders - Bile Acid Salts
2024-PHARM-65 Heart Disease/Hyperlipidemia - Lipotropics, Other 8/5/24 9/19/24 Complete Heart Disease/Hyperlipidemia - Lipotropics, Other
2024-PHARM-66 Lenmeldy 8/5/24 9/19/24 Complete Lenmeldy
2024-PHARM-67 Louisiana Medicaid ICD-10 Chart 8/5/24 9/19/24 Complete Louisiana Medicaid ICD-10 Chart
2024-PHARM-68 Pain Management - Cytokine/CAM Antagonists 8/5/24 9/19/24 Complete Pain Management - Cytokine/CAM Antagonists
2024-PHARM-69 POS Antipsychotic Agents, Injectable Agents 8/5/24 9/19/24 Complete POS Antipsychotic Agents, Injectable Agents
2024-PHARM-70 POS Anxiolytics 8/5/24 9/19/24 Complete POS Anxiolytics
2024-PHARM-71 POS Depression - Antidepressants, Other 8/5/24 9/19/24 Complete POS Depression - Antidepressants, Other
2024-PHARM-72 POS Dermatology - Atopic Dermatitis, Immunomodulators 8/5/24 9/19/24 Complete POS Dermatology - Atopic Dermatitis, Immunomodulators
2024-PHARM-73 POS Infectious Disorders - Hepatitis C Agents, Direct Acting Antiviral Agents 8/5/24 9/19/24 Complete POS Infectious Disorders - Hepatitis C Agents, Direct Acting Antiviral Agents
2024-PHARM-74 POS Opiate Dependence Agents 8/5/24 9/19/24 Complete POS Opiate Dependence Agents
2024-PHARM-75 POS Opsynvi 8/5/24 9/19/24 Complete POS Opsynvi
2024-PHARM-76 POS Progestational Agents 8/5/24 9/19/24 Complete POS Progestational Agents
2024-PHARM-77 POS Voydeya 8/5/24 9/19/24 Complete POS Voydeya
2024-PHARM-78 POS Wegovy 8/5/24 9/19/24 Complete POS Wegovy
2024-PHARM-79 POS Winrevair 8/5/24 9/19/24 Complete POS Winrevair
2024-PHARM-80 Rezdiffra 8/5/24 9/19/24 Complete Rezdiffra
2024-PHARM-81 Simlandi 8/5/24 9/19/24 Complete Simlandi
2024-PHARM-82 Tofidence 8/5/24 9/19/24 Complete Tofidence
2024-PHARM-83 Tyenne 8/5/24 9/19/24 Complete Tyenne
2024-ACLA-MED-73 Adzynma 8/5/24 9/19/24 Complete Adzynma
2024-ACLA-MED-74 Alpha 1 Proteinase Inhibitors 8/5/24 9/19/24 Complete Alpha 1 Proteinase Inhibitors
2024-ACLA-MED-76 Hydroxyprogesterone 8/5/24 9/19/24 Complete Hydroxyprogesterone
2024-ACLA-MED-77 Ketamine 8/5/24 9/19/24 Complete Ketamine
2024-ACLA-MED-78 Lamzede 8/5/24 9/19/24 Complete Lamzede
2024-ACLA-MED-79 Myasthenia Gravis Agents 8/5/24 9/19/24 Complete Myasthenia Gravis Agents
2024-ACLA-MED-80 Oncology Drugs 8/5/24 9/19/24 Complete Oncology Drugs
2024-ACLA-MED-81 Radicava 8/5/24 9/19/24 Complete Radicava
2024-ACLA-MED-82 Somatostatin Analogs 8/5/24 9/19/24 Complete Somatostatin Analogs
2024-ACLA-MED-83 Specialty Drugs 8/5/24 9/19/24 Complete Specialty Drugs
2024-ACLA-MED-84 Transthyretin-mediated Amyloidosis 8/5/24 9/19/24 Complete Transthyretin-mediated Amyloidosis
2024-LHCC-MED-590 Dornase alfa (Pulmozyme) 8/5/24 9/19/24 Complete Dornase alfa (Pulmozyme)
2024-LHCC-MED-591  Motixafortide (Aphexda) 8/5/24 9/19/24 Complete Motixafortide (Aphexda)
2024-LHCC-MED-592 Lifileucel (Amtagvi) 8/5/24 9/19/24 Complete Lifileucel (Amtagvi)
2024-LHCC-MED-593 Sodium thiosulfate (Pedmark) 8/5/24 9/19/24 Complete Sodium thiosulfate (Pedmark)
2024-LHCC-MED-594 Pozelimab-bbfg (Veopoz) 8/5/24 9/19/24 Complete Pozelimab-bbfg (Veopoz)
2024-LHCC-MED-595 Talquetamab-tgvs (Talvey) 8/5/24 9/19/24 Complete Talquetamab-tgvs (Talvey)
2024-LHCC-MED-596 DaxibotulinumtoxinA-lanm (Daxxify) 8/5/24 9/19/24 Complete DaxibotulinumtoxinA-lanm (Daxxify)
2024-LHCC-MED-597 Elranatamab-bcmm (Elrexfio) 8/5/24 9/19/24 Complete Elranatamab-bcmm (Elrexfio)
2024-HUMANA-MED-108 LA PAL State review 8/5/24 9/19/24 Complete LA PAL State review
2024-HUMANA-MED-109 HCPCS J7202 Indelvion 8/5/24 9/19/24 Complete HCPCS J7202 Indelvion
2024-HB-MED-366 Elfabrio, Epkinly, Vyjuvek, Zynyz 8/5/24 9/19/24 Complete Elfabrio, Epkinly, Vyjuvek, Zynyz
2024-UHC-MED-218 Self-administered medications 8/5/24 9/19/24 Complete Self-administered medications
2024-UHC-MED-219 Complement inhibitors (Soliris, Ultomiris) 8/5/24 9/19/24 Complete Complement inhibitors (Soliris, Ultomiris)
2024-PHARM-60 Wegovy 8/1/24 9/15/24 Complete Wegovy
2024-HUMANA-MED-97 7417_Vedolizumab 7/12/24 8/26/24 Complete 7417_Vedolizumab
2024-HUMANA-MED-98 7426, 7428, 7429, 7432_Pemetrexed 7/12/24 8/26/24 Complete 7426, 7428, 7429, 7432_Pemetrexed
2024-HUMANA-MED-99 7477, 7479, 7481, 7483_Tocilizumab 7/12/24 8/26/24 Complete 7477, 7479, 7481, 7483_Tocilizumab
2024-HUMANA-MED-100 7412, 7415_Aflibercept 7/12/24 8/26/24 Complete 7412, 7415_Aflibercept
2024-HUMANA-MED-101 7407_Irinotecan 7/12/24 8/26/24 Complete 7407_Irinotecan
2024-HUMANA-MED-102 7424_Omalizumab 7/12/24 8/26/24 Complete 7424_Omalizumab
2024-HUMANA-MED-103 7443_Adalimumab 7/12/24 8/26/24 Complete 7443_Adalimumab
2024-HUMANA-MED-104 7462_Pegfilgrastim 7/12/24 8/26/24 Complete 7462_Pegfilgrastim
2024-HUMANA-MED-105 7410_Nivolumab 7/12/24 8/26/24 Complete 7410_Nivolumab
2024-HUMANA-MED-106 7445_Ipilimumab 7/12/24 8/26/24 Complete 7445_Ipilimumab
2024-HUMANA-MED-107 7501_Ritiliximab 7/12/24 8/26/24 Complete 7501_Ritiliximab
2024-LHCC-MED-575 Sipuleucel-T (Provenge) 7/8/24 8/22/24 Complete Sipuleucel-T (Provenge)
2024-LHCC-MED-576 Pertuzumab (Perjeta) 7/8/24 8/22/24 Complete Pertuzumab (Perjeta)
2024-LHCC-MED-577 Cabazitaxel (Jevtana) 7/8/24 8/22/24 Complete Cabazitaxel (Jevtana)
2024-LHCC-MED-578 Ipilimumab (Yervoy) 7/8/24 8/22/24 Complete Ipilimumab (Yervoy)
2024-LHCC-MED-579 Patisiran (Onpattro) 7/8/24 8/22/24 Complete Patisiran (Onpattro)
2024-LHCC-MED-580 Dexrazoxane (Totect) 7/8/24 8/22/24 Complete Dexrazoxane (Totect)
2024-LHCC-MED-581 Sacituzumab govitecan-hziy (Trodelvy) 7/8/24 8/22/24 Complete Sacituzumab govitecan-hziy (Trodelvy)
2024-LHCC-MED-582 Letermovir (Prevymis) 7/8/24 8/22/24 Complete Letermovir (Prevymis)
2024-LHCC-MED-583 Bezlotoxumab (Zinplava) 7/8/24 8/22/24 Complete Bezlotoxumab (Zinplava)
2024-LHCC-MED-584 Pembrolizumab (Keytruda) 7/8/24 8/22/24 Complete Pembrolizumab (Keytruda)
2024-LHCC-MED-585 Blinatumomab (Blincyto) 7/8/24 8/22/24 Complete Blinatumomab (Blincyto)
2024-LHCC-MED-586 Omecetaxine (Synribo) 7/8/24 8/22/24 Complete Omecetaxine (Synribo)
2024-LHCC-MED-587 Sebelipase alfa (Kanuma) 7/8/24 8/22/24 Complete Sebelipase alfa (Kanuma)
2024-LHCC-MED-588 Ado-trastuzumab (Kadcyla) 7/8/24 8/22/24 Complete Ado-trastuzumab (Kadcyla)
2024-LHCC-MED-589 Elapegademase-lvlr (Revcovi) 7/8/24 8/22/24 Complete Elapegademase-lvlr (Revcovi)
2024-UHC-MED-214 Maximum dosage and frequency 7/8/24 8/22/24 Complete Maximum dosage and frequency
2024-UHC-MED-215 Oncology medication clinical coverage 7/8/24 8/22/24 Complete Oncology medication clinical coverage
2024-UHC-MED-216 RNA-targeted therapies 7/8/24 8/22/24 Complete RNA-targeted therapies
2024-UHC-MED-217 Rituxan-rituximab 7/8/24 8/22/24 Complete Rituxan-rituximab
2024-LHCC-MED-534 Alglucosidase (Lumizyme) 6/24/24 8/8/24 Complete Alglucosidase (Lumizyme)
2024-LHCC-MED-535 Trabectedin (Yondelis) 6/24/24 8/8/24 Complete Trabectedin (Yondelis)
2024-LHCC-MED-536 Paricalcitol Injection (Zemplar) 6/24/24 8/8/24 Complete Paricalcitol Injection (Zemplar)
2024-LHCC-MED-537 Brentuximab Vedotin (Adcetris) 6/24/24 8/8/24 Complete Brentuximab Vedotin (Adcetris)
2024-LHCC-MED-538 Elotuzumab (Empliciti) 6/24/24 8/8/24 Complete Elotuzumab (Empliciti)
2024-LHCC-MED-539 Carfilzomib (Kyprolis) 6/24/24 8/8/24 Complete Carfilzomib (Kyprolis)
2024-LHCC-MED-540 Daratumumab Daratumumab-Hyaluronidase-fihj (Darzalex, Darzalex, Faspro) 6/24/24 8/8/24 Complete Daratumumab Daratumumab-Hyaluronidase-fihj (Darzalex, Darzalex, Faspro)
2024-LHCC-MED-541 Cetuximab (Erbitux) 6/24/24 8/8/24 Complete Cetuximab (Erbitux)
2024-LHCC-MED-542 Siltuximab (Sylvant) 6/24/24 8/8/24 Complete Siltuximab (Sylvant)
2024-LHCC-MED-543 Avelumab (Bavencio) 6/24/24 8/8/24 Complete Avelumab (Bavencio)
2024-LHCC-MED-544 Lutetium Lu 177 Dotatate (Lutathera) 6/24/24 8/8/24 Complete Lutetium Lu 177 Dotatate (Lutathera)
2024-LHCC-MED-545 Azacitidine (Onureg, Vidaza) 6/24/24 8/8/24 Complete Azacitidine (Onureg, Vidaza)
2024-LHCC-MED-546 Moxetumomab pasudotox-tdfk (Lumoxiti) 6/24/24 8/8/24 Complete Moxetumomab pasudotox-tdfk (Lumoxiti)
2024-LHCC-MED-547 Denosumab (Xgeva) 6/24/24 8/8/24 Complete Denosumab (Xgeva)
2024-LHCC-MED-548 Paclitaxel protein-bound (Abraxane) 6/24/24 8/8/24 Complete Paclitaxel protein-bound (Abraxane)
2024-LHCC-MED-549 Atezolizumab (Tecentriq) 6/24/24 8/8/24 Complete Atezolizumab (Tecentriq)
2024-LHCC-MED-550 Erwinia Asparaginase (Erwinaze, Rylaze) 6/24/24 8/8/24 Complete Erwinia Asparaginase (Erwinaze, Rylaze)
2024-LHCC-MED-551 Cerliponase alfa (Brineura) 6/24/24 8/8/24 Complete Cerliponase alfa (Brineura)
2024-LHCC-MED-552 Tisagenlecleucel (Kymriah) 6/24/24 8/8/24 Complete Tisagenlecleucel (Kymriah)
2024-LHCC-MED-553 Axicabtagene ciloleucel (Yescarta) 6/24/24 8/8/24 Complete Axicabtagene ciloleucel (Yescarta)
2024-LHCC-MED-554 Octreotide Acetate (Sandostatin, Sandostatin LAR, Bynfezia, Mycapssa) 6/24/24 8/8/24 Complete Octreotide Acetate (Sandostatin, Sandostatin LAR, Bynfezia, Mycapssa)
2024-LHCC-MED-555 Emapalumab-lzsg (Gamifant) 6/24/24 8/8/24 Complete Emapalumab-lzsg (Gamifant)
2024-LHCC-MED-556 Fam-trastuzumab deruxtecan-nxki (Enhertu) 6/24/24 8/8/24 Complete Fam-trastuzumab deruxtecan-nxki (Enhertu)
2024-LHCC-MED-557 Teprotumumab (Tepezza) 6/24/24 8/8/24 Complete Teprotumumab (Tepezza)
2024-LHCC-MED-558 Ramucirumab (Cyramza) 6/6/24 7/21/24 Complete Ramucirumab (Cyramza)
2024-LHCC-MED-559 Nivolumab (Opdivo) 6/6/24 7/21/24 Complete Nivolumab (Opdivo)
2024-LHCC-MED-560 Deferoxamine (Desferal) 6/6/24 7/21/24 Complete Deferoxamine (Desferal)
2024-LHCC-MED-561 Trastuzumab Biosimilars Trastuzumab-Hyaluronidase 6/6/24 7/21/24 Complete Trastuzumab Biosimilars Trastuzumab-Hyaluronidase
2024-LHCC-MED-562 Rituximab (Rituxan, Riabni, Ruxience, Truxima, Rituxan Hycela) 6/6/24 7/21/24 Complete Rituximab (Rituxan, Riabni, Ruxience, Truxima, Rituxan Hycela)
2024-LHCC-MED-563 Durvalumab (Imfinzi) 6/6/24 7/21/24 Complete Durvalumab (Imfinzi)
2024-LHCC-MED-564 Cemiplimab-rwlc (Libtayo) 6/6/24 7/21/24 Complete Cemiplimab-rwlc (Libtayo)
2024-LHCC-MED-565 Enfortumab Vedotin-ejfv (Padcev) 6/6/24 7/21/24 Complete Enfortumab Vedotin-ejfv (Padcev)
2024-LHCC-MED-566 Faricimab (Vabysmo) 6/6/24 7/21/24 Complete Faricimab (Vabysmo)
2024-LHCC-MED-567 Bevacizumab (Alymsys, Avastin, Mvasi, Vegzelma, Zirabev) 6/6/24 7/21/24 Complete Bevacizumab (Alymsys, Avastin, Mvasi, Vegzelma, Zirabev)
2024-LHCC-MED-568 Alpha1-Proteinase Inhibitors (Aralast NP, Glassia, Prolastin-C, Zemaira) 6/6/24 7/21/24 Complete Alpha1-Proteinase Inhibitors (Aralast NP, Glassia, Prolastin-C, Zemaira)
2024-LHCC-MED-569 Ravulizumab-cwvz (Ultomiris) 6/6/24 7/21/24 Complete Ravulizumab-cwvz (Ultomiris)
2024-LHCC-MED-570 Bendamustine (Belrapzo, Bendeka, Treanda, Vivimusta) 6/6/24 7/21/24 Complete Bendamustine (Belrapzo, Bendeka, Treanda, Vivimusta)
2024-LHCC-MED-571 Daptomycin (Cubicin, Cubicin RF, Dapzura RT) 6/6/24 7/21/24 Complete Daptomycin (Cubicin, Cubicin RF, Dapzura RT)
2024-LHCC-MED-572 Bortezomib (Velcade) 6/6/24 7/21/24 Complete Bortezomib (Velcade)
2024-LHCC-MED-573 Efgartigimod Alfa-fcab (Vyvgart) 6/6/24 7/21/24 Complete Efgartigimod Alfa-fcab (Vyvgart)
2024-LHCC-MED-574 Pemetrexed (Alimta, Pemfexy) 6/6/24 7/21/24 Complete Pemetrexed (Alimta, Pemfexy)
2024-LHCC-MED-531 Ferumoxytol (Feraheme) 6/4/24 7/19/24 Complete Ferumoxytol (Feraheme)
2024-LHCC-MED-532 Ibandronate injection (Boniva) 6/4/24 7/19/24 Complete Ibandronate injection (Boniva)
2024-LHCC-MED-533 Ferric Carboxymaltose (Injectafer) 6/4/24 7/19/24 Complete Ferric Carboxymaltose (Injectafer)
2024-LHCC-MED-511 Iptacopan (Fabhalta) 6/4/24 7/19/24 Complete Iptacopan (Fabhalta)
2024-LHCC-MED-512 Toripalimab-tpzi (Loqtorzi) 6/4/24 7/19/24 Complete Toripalimab-tpzi (Loqtorzi)
2024-LHCC-MED-513 Aprocitentan (Tryvio) 6/4/24 7/19/24 Complete Aprocitentan (Tryvio)
2024-LHCC-MED-514 Vadadustat (Vafseo) 6/4/24 7/19/24 Complete Vadadustat (Vafseo)
2024-LHCC-MED-515 Edaravone (Radicava) 6/4/24 7/19/24 Complete Edaravone (Radicava)
2024-LHCC-MED-516 Triamcinolone ER Injection (Zilretta) 6/4/24 7/19/24 Complete Triamcinolone ER Injection (Zilretta)
2024-LHCC-MED-517 Epoprostenol (Flolan, Veletri) 6/4/24 7/19/24 Complete Epoprostenol (Flolan, Veletri)
2024-LHCC-MED-518 Hemin (Panhematin) 6/4/24 7/19/24 Complete Hemin (Panhematin)
2024-LHCC-MED-519 Verteporfin (Visudyne) 6/4/24 7/19/24 Complete Verteporfin (Visudyne)
2024-LHCC-MED-520 Cosyntropin (Cortrosyn) 6/4/24 7/19/24 Complete Cosyntropin (Cortrosyn)
2024-LHCC-MED-521 Asfotase Alfa (Strensiq) 6/4/24 7/19/24 Complete Asfotase Alfa (Strensiq)
2024-LHCC-MED-522 Protein C Concentrate Human (Ceprotin) 6/4/24 7/19/24 Complete Protein C Concentrate Human (Ceprotin)
2024-LHCC-MED-523 Voretigene Neparvovec-rzyl (Luxturna) 6/4/24 7/19/24 Complete Voretigene Neparvovec-rzyl (Luxturna)
2024-LHCC-MED-524 Inotersen (Tegsedi) 6/4/24 7/19/24 Complete Inotersen (Tegsedi)
2024-LHCC-MED-525 Trofinetide (Daybue) 6/4/24 7/19/24 Complete Trofinetide (Daybue)
2024-LHCC-MED-526 Eculizumab (Soliris) 6/4/24 7/19/24 Complete Eculizumab (Soliris)
2024-LHCC-MED-527 Agalsidase beta (Fabrazyme) 6/4/24 7/19/24 Complete Agalsidase beta (Fabrazyme)
2024-LHCC-MED-528 Interferon Gamma-1b (Actimmune) 6/4/24 7/19/24 Complete Interferon Gamma-1b (Actimmune)
2024-LHCC-MED-529 Ranibizumab (Lucentis, Susvimo), Lucentis Biosimilars 6/4/24 7/19/24 Complete Ranibizumab (Lucentis, Susvimo), Lucentis Biosimilars
2024-LHCC-MED-530 Sutimlimab-jome (Enjaymo) 6/4/24 7/19/24 Complete Sutimlimab-jome (Enjaymo)


Surgeon General Ralph L. Abraham, M.D.

Secretary Bruce D. Greenstein

Powered by Cicero Government